Miss Nicola Greenlaw

  • Consultant Bio Statistician (Robertson Centre for Biostatistics)

telephone: 01413303732
email: Nicola.Greenlaw@glasgow.ac.uk

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • Older parent carers health and its reciprocal effect on their ageing offspring with intellectual disabilities: a record linkage study
    Baily Thomas Charitable Fund
    2018 - 2019
     
  • Predictors of mental ill-health in mothers caring for a son or daughter with intelectual disabilities
    Economic and Social Research Council
    2017 - 2019
     
  • How do arrhythmias and conduction disturbances contribute to death or rehospitalisation in patients discharged following an admission with acute heart failure? A prospective, observational, multi-centre cohort-study
    British Heart Foundation
    2017 - 2022
     
  • Poor oral health in adults with intellectual disabilities and its determinants: Secondary analysis of linked administrative and health records
    Baily Thomas Charitable Fund
    2017 - 2018
     
  • Intravenous iron treatment in patients with heart failure and iron deficiency: a multicentre UK study (IRONMAN)
    British Heart Foundation
    2016 - 2020
     
  • Intravenous iron treatment in patients with heart failure and iron deficiency: a multicentre UK study (IRONMAN)
    Pharmacosmos A/S
    2015 - 2020
     
  • Testing Emotionalism After Stroke (TEARS)
    Stroke Association
    2015 - 2019
     
  • Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease (ALL HEART).
    National Institute for Health Research
    2013 - 2019
     
  • Towards onset prevention of cognitive decline in adults with Down syndrome
    Chief Scientist Office
    2012 - 2014
     
  • Setting priorities and reducing uncertainties in the prevention and treatment of people with skin diseases
    National Institute for Health Research
    2008 - 2013
     

Publications

List by: Type | Date

Jump to: 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010
Number of items: 53.

2019

Gandhi, S. et al. (2019) Living alone and cardiovascular disease outcomes. Heart, (doi:10.1136/heartjnl-2018-313844) (PMID:30792241) (Early Online Publication)

2018

Sorbets, E. et al. (2018) β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study. European Heart Journal, (doi:10.1093/eurheartj/ehy811) (PMID:30590529) (Early Online Publication)

Kalra, P. R., Greenlaw, N., Ford, I. , Steg, P. G. and Fox, K. M. (2018) The reply. American Journal of Medicine, 131(3), e129. (doi:10.1016/j.amjmed.2017.09.019) (PMID:29454433)

Cooper, S.-A. et al. (2018) Management and prevalence of long-term conditions in primary health care for adults with intellectual disabilities compared with the general population: a population-based cohort study. Journal of Applied Research in Intellectual Disabilities, 31(S1), pp. 68-81. (doi:10.1111/jar.12386) (PMID:28730746)

Vidal-Petiot, E., Greenlaw, N., Ford, I. , Ferrari, R., Fox, K. M., Tardif, J.-C., Tendera, M., Parkhomenko, A., Bhatt, D. L. and Steg, P. G. (2018) Relationships between components of blood pressure and cardiovascular events in patients with stable coronary artery disease and hypertension. Hypertension, 71, pp. 168-176. (doi:10.1161/HYPERTENSIONAHA.117.10204) (PMID:29084876)

2017

Lang, I. M., Badr-Eslam, R., Greenlaw, N., Young, R. and Steg, P. G. (2017) Management and clinical outcome of stable coronary artery disease in Austria: results from 5 years of the CLARIFY registry. Wiener Klinische Wochenschrift, 129(23-24), pp. 879-892. (doi:10.1007/s00508-017-1248-1) (PMID:28913755) (PMCID:PMC5860132)

Chee, K. H., Choo, G. H., Jamaluddin, A. N., Mahendran, K., Greenlaw, N. and Krishnan, C. (2017) Clinical characteristics, treatment and 2-year outcomes in Malaysian and Bruneian patients with stable coronary artery within the worldwide CLARIFY registry. Medical Journal of Malaysia, 72(5), pp. 282-285. (PMID:29197883)

Sorbets, E., Greenlaw, N., Ferrari, R., Ford, I. , Fox, K. M., Tardif, J.-C., Tendera, M. and Steg, P. G. (2017) Rationale, design, and baseline characteristics of the CLARIFY registry of outpatients with stable coronary artery disease. Clinical Cardiology, 40(10), pp. 797-806. (doi:10.1002/clc.22730) (PMID:28561986) (PMCID:PMC5697615)

Petrie, J. R. et al. (2017) Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial. Lancet Diabetes and Endocrinology, 5(8), pp. 597-609. (doi:10.1016/S2213-8587(17)30194-8) (PMID:28615149)

Kalra, P. R. et al. (2017) Hemoglobin and change in hemoglobin status predict mortality, cardiovascular events and bleeding in stable coronary artery disease. American Journal of Medicine, 130(6), pp. 720-730. (doi:10.1016/j.amjmed.2017.01.002) (PMID:28109968)

MacDonald, T. M. et al. (2017) Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT). European Heart Journal, 38(23), pp. 1843-1850. (doi:10.1093/eurheartj/ehw387) (PMID:27705888)

Parma, Z. et al. (2017) Differences in outcomes in patients with stable coronary artery disease managed by cardiologists versus non-cardiologists: the international prospective CLARIFY registry. Polish Archives of Internal Medicine, 127(2), pp. 107-114. (doi:10.20452/pamw.3902)

2016

Thomas, K. S., Ormerod, A. D., Craig, F., Greenlaw, N., Norrie, J., Mitchell, E., Mason, J. M., Johnston, G. A., Wahie, S. and Williams, H. C. (2016) Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: a prospective cohort study. Journal of the American Academy of Dermatology, 75(5), pp. 940-949. (doi:10.1016/j.jaad.2016.06.016) (PMID:27502313)

Vidal-Petiot, E., Ford, I. , Greenlaw, N., Ferrari, R., Fox, K. M., Tardif, J.-C., Tendera, M., Tavazzi, L., Bhatt, D. L. and Steg, P. G. (2016) Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study. Lancet, 388(10056), pp. 2142-2152. (doi:10.1016/S0140-6736(16)31326-5) (PMID:27590221)

Cooper, S.-A. et al. (2016) Towards onset prevention of cognition decline in adults with Down syndrome (The TOP-COG study): a pilot randomised controlled trial. Trials, 17, 370. (doi:10.1186/s13063-016-1370-9) (PMID:27473843) (PMCID:PMC4966871)

Hughes-Mccormack, L. et al. (2016) Quality of primary health care of 5,000 people with intellectual disabilities in Scotland. 2016 IASSIDD World Congress, Melbourne, Australia, 14-19 Aug 2016. p. 685. (doi:10.1111/jir.12305)

McMurray, J. J.V. et al. (2016) Aliskiren, enalapril, or aliskiren and enalapril in heart failure. New England Journal of Medicine, 374(16), pp. 1521-1532. (doi:10.1056/NEJMoa1514859) (PMID:27043774)

2015

Alcocer-Gamba, M. A., Martínez-Sánchez, C., Verdejo-Paris, J., Ferrari, R., Fox, K., Greenlaw, N. and Steg Philippe, G. (2015) Heart rate and use of -blockers in Mexican stable outpatients with coronary artery disease. Archivos de Cardiología de México, pp. 270-277. (doi:10.1016/j.acmx.2015.01.004) (PMID:25921309)

Ponikowski, P. et al. (2015) The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study. European Journal of Heart Failure, 17(3), pp. 329-339. (doi:10.1002/ejhf.229) (PMID:25683972) (PMCID:PMC4413361)

Sbarouni, E., Voudris, V., Georgiadou, P., Hamilos, M., Steg, G., Fox, K. M., Greenlaw, N. and Vardas, P. E. (2015) Heart rate and b-blockade in stable coronary artery disease in Greece. Hellenic Journal of Cardiology, 56, pp. 112-117.

Erglis, A., Mintale, I., Latkovskis, G., Balode, I., Jegere, S., Bajare, I., Rozenbergs, A., Greenlaw, N., Ferrari, R. and Steg, P. G. (2015) Management of coronary artery disease patients in Latvia compared with practice in Central-Eastern Europe and globally: analysis of the CLARIFY registry. Medicina, 51(4), pp. 240-246. (doi:10.1016/j.medici.2015.05.004) (PMID:26424189)

Fauchier, L., Greenlaw, N., Ferrari, R., Ford, I. , Fox, K. M., Tardif, J.-C., Tendera, M. and Steg, P. G. (2015) Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International CLARIFY registry. PLoS ONE, 10(4), e0125164. (doi:10.1371/journal.pone.0125164) (PMID:25915904) (PMCID:PMC4411156)

Ormerod, A.D., Thomas, K.S., Craig, F.E., Mitchell, E., Greenlaw, N., Norrie, J., Mason, J.M., Walton, S., Johnston, G.A. and Williams, H.C. (2015) Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial. British Medical Journal, 2015(350), h2958. (doi:10.1136/bmj.h2958) (PMID:26071094) (PMCID:PMC4469977)

2014

Cooper, S.-A. et al. (2014) Practice nurse health checks for adults with intellectual disabilities: a cluster-design, randomised controlled trial. Lancet Psychiatry, 1(7), pp. 511-521. (doi:10.1016/S2215-0366(14)00078-9)

Sbarouni, E., Voudris, V., Georgiadou, P., Hamilos, M., Steg, P. G., Fox, K. M., Greenlaw, N., Ferrari, R. and Vardas, P. E. (2014) Clinical presentation and management of stable coronary artery disease: insights from the international prospective CLARIFY registry - results from the Greek National Cohort. Hellenic Journal of Cardiology, 55, pp. 442-447. (PMID:25432195)

Steg, P. G. et al. (2014) Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the international observational CLARIFY registry. JAMA Internal Medicine, 174(10), pp. 1651-1659. (doi:10.1001/jamainternmed.2014.3773) (PMID:25110899)

Tendera, M. et al. (2014) Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registry. International Journal of Cardiology, 176(1), pp. 119-124. (doi:10.1016/j.ijcard.2014.06.052) (PMID:25042656)

Danchin, N., Ferrieres, J., Guenoun, M., Cattan, S., Rushton-Smith, S. K., Greenlaw, N., Ferrari, R. and Steg, P. G. (2014) Management of outpatients in France with stable coronary artery disease. Findings from the prospeCtive observational LongitudinAl RegIstry oF patients with stable coronary arterY disease (CLARIFY) registry. Archives of Cardiovascular Diseases, 107(8-9), pp. 452-461. (doi:10.1016/j.acvd.2014.06.001) (PMID:25128934)

Zamorano, J. L., García-Moll, X., Ferrari, R. and Greenlaw, N. (2014) Demographic and clinical characteristics of patients with stable coronary artery disease: results from the CLARIFY registry in Spain. Revista Española de Cardiología (English Edition), 67(7), pp. 538-544. (doi:10.1016/j.rec.2013.10.020) (PMID:24952393)

Gandhi, S., Dorian, P., Greenlaw, N., Tardif, J.-C., Steg, P.G., Huynh, T., Wong, G.C., Love, M.P., Poirier, P. and Goodman, S.G. (2014) Characteristics and evidence-based management of stable coronary artery disease patients in Canada compared with the rest of the world: insights from the CLARIFY registry. Canadian Journal of Cardiology, 30(1), pp. 132-137. (doi:10.1016/j.cjca.2013.07.680) (PMID:24238756)

Balode, I., Mintāle, I., Latkovskis, G., Jēgere, S., Narbute, I., Bajāre, I., Greenlaw, N., Steg, P. G., Ferrari, R. and Ērglis, A. (2014) Insufficient control of heart rate in stable coronary artery disease patients in Latvia. Medicina, 50(5), pp. 295-302. (doi:10.1016/j.medici.2014.10.005) (PMID:25488166)

Ferrari, R., Ford, I. , Greenlaw, N., Tardif, J.-C., Tendera, M., Abergel, H., Fox, K., Hu, D., Shalnova, S. and Steg, P. G. (2014) Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: data from the contemporary CLARIFY registry. European Journal of Preventive Cardiology, 22(8), pp. 1056-1065. (doi:10.1177/2047487314547652) (PMID:25147344)

Kalra, P. R. et al. (2014) Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patients. PLoS ONE, 9(7), e102335. (doi:10.1371/journal.pone.0102335) (PMID:25051258) (PMCID:PMC4106833)

McMurray, J. et al. (2014) A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure. European Heart Journal, 36(7), pp. 434-439. (doi:10.1093/eurheartj/ehu455) (PMID:25416329) (PMCID:PMC4328198)

Stępińska, J., Marona, M., Greenlaw, N. and Steg, G. (2014) Heart rate and the use of beta-blockers in stable outpatients with coronary artery disease: Polish baseline results of the CLARIFY registry. Kardiologia Polska, 72(11), pp. 1156-1164. (doi:10.5603/KP.a2014.0134) (PMID:25001472)

2013

Cameron, E.J. et al. (2013) Randomised controlled trial of azithromycin in smokers with asthma. European Respiratory Journal, 42(5), pp. 1412-1415. (doi:10.1183/09031936.00093913)

Ferrari, R., Abergel, H., Ford, I. , Fox, K.M., Greenlaw, N., Steg, P.G., Hu, D., Tendera, M. and Tardif, J. (2013) Gender- and age-related differences in clinical presentation and management of outpatients with stable coronary artery disease. International Journal of Cardiology, 167(6), pp. 2938-2943. (doi:10.1016/j.ijcard.2012.08.013) (PMID:22985742)

Wright, F., Boyle, S., Baxter, K., Gilchrist, L., Nellaney, J., Greenlaw, N. and Forde, L. (2013) Understanding the relationship between weight loss, emotional well-being and health-related quality of life in patients attending a specialist obesity weight management service. Journal of Health Psychology, 18(4), pp. 574-586. (doi:10.1177/1359105312451865)

Filippatos, G. et al. (2013) Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial. European Journal of Heart Failure, 15(11), pp. 1267-1276. (doi:10.1093/eurjhf/hft099)

Jackson, C.E. et al. (2013) Spectral microvolt T-wave alternans testing has no prognostic value in patients recently hospitalized with decompensated heart failure. European Journal of Heart Failure, 15(11), pp. 1253-1261. (doi:10.1093/eurjhf/hft085)

Jackson, C.E. et al. (2013) Feasibility/eligibility of T-wave alternans testing in patients with heart failure: should we rethink our current modus operandi?: reply. European Journal of Heart Failure, 14(6), pp. 676-677. (doi:10.1093/eurjhf/hfs050)

Smith, S., Allan, A., Greenlaw, N., Finlay, S. and Isles, C. (2013) Emergency medical admissions, deaths at weekends and the public holiday effect. Cohort study. Emergency Medicine Journal, 2014(31), pp. 30-34. (doi:10.1136/emermed-2012-201881)

Van Craenenbroeck, E.M., Conraads, V.M., Greenlaw, N., Gaudesius, G., Mori, C., Ponikowski, P. and Anker, S.D. (2013) The effect of intravenous ferric carboxymaltose on red cell distribution width: a subanalysis of the FAIR-HF study. European Journal of Heart Failure, 15(7), pp. 756-762. (doi:10.1093/eurjhf/hft068)

2012

Steg, P.G., Greenlaw, N., Tardif, J.-C., Tendera, M., Ford, I. , Kaab, S., Abergel, H., Fox, K.M. and Ferrari, R. (2012) Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry. European Heart Journal, 33(22), pp. 2831-2840. (doi:10.1093/eurheartj/ehs289)

Lowrie, R., Mair, F.S. , Greenlaw, N., Forsyth, P., Jhund, P.S. , McConnachie, A. , Rae, B. and McMurray, J.J.V. (2012) Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction. European Heart Journal, 33(3), pp. 314-324. (doi:10.1093/eurheartj/ehr433)

Jackson, C.E. et al. (2012) Microvolt T-wave alternans (MTWA) testing in 'real world' heart failure (HF): a study of prevalence and incremental prognostic value. Heart, 2012(98), A12. (doi:10.1136/heartjnl-2012-301877b.17)

Jackson, C.E. et al. (2012) Microvolt T-wave alternans testing should be used to guide arrhythmic therapy in heart failure patients: reply. European Journal of Heart Failure, 14(6), p. 678. (doi:10.1093/eurjhf/hfs077)

Jackson, C.E. et al. (2012) Profile of microvolt T-wave alternans testing in 1003 patients hospitalized with heart failure. European Journal of Heart Failure, 14(4), pp. 377-386. (doi:10.1093/eurjhf/hfs010)

Morrison, D.S., Boyle, S., Morrison, C., Allardice, G., Greenlaw, N. and Forde, L. (2012) Evaluation of the first phase of a specialist weight management programme in the UK National Health Service: prospective cohort study. Public Health Nutrition, 15(1), pp. 28-38. (doi:10.1017/S1368980011001625)

Steg, P.G., Ferrari, R., Ford, I. , Greenlaw, N., Tardif, J.-C., Tendera, M., Abergel, H. and Fox, K. (2012) Heart rate and use of beta-blockers in stable outpatients with coronary artery disease. PLoS ONE, 7(5), e36284. (doi:10.1371/journal.pone.0036284) (PMID:22570699) (PMCID:PMC3343045)

2011

Lowrie, R. et al. (2011) The Heart failure and Optimal Outcomes from Pharmacy Study (HOOPS): rationale, design, and baseline characteristics. European Journal of Heart Failure, 13(8), pp. 917-924. (doi:10.1093/eurjhf/hfr083)

2010

McArdle, C.S., McMillan, D.C. , Greenlaw, N. and Morrison, D.S. (2010) Adjuvant radiotherapy and chemotherapy in breast cancer: 30 year follow-up of survival. BMC Cancer, 10(1), p. 398. (doi:10.1186/1471-2407-10-398)

Robertson, G., Greenlaw, N., Bray, C. and Morrison, D. (2010) Explaining the effects of socio-economic deprivation on survival in a national prospective cohort study of 1909 patients with head and neck cancers. Cancer Epidemiology, 34(6), pp. 682-688.

This list was generated on Tue Jul 16 07:35:20 2019 BST.
Number of items: 53.

Articles

Gandhi, S. et al. (2019) Living alone and cardiovascular disease outcomes. Heart, (doi:10.1136/heartjnl-2018-313844) (PMID:30792241) (Early Online Publication)

Sorbets, E. et al. (2018) β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study. European Heart Journal, (doi:10.1093/eurheartj/ehy811) (PMID:30590529) (Early Online Publication)

Kalra, P. R., Greenlaw, N., Ford, I. , Steg, P. G. and Fox, K. M. (2018) The reply. American Journal of Medicine, 131(3), e129. (doi:10.1016/j.amjmed.2017.09.019) (PMID:29454433)

Cooper, S.-A. et al. (2018) Management and prevalence of long-term conditions in primary health care for adults with intellectual disabilities compared with the general population: a population-based cohort study. Journal of Applied Research in Intellectual Disabilities, 31(S1), pp. 68-81. (doi:10.1111/jar.12386) (PMID:28730746)

Vidal-Petiot, E., Greenlaw, N., Ford, I. , Ferrari, R., Fox, K. M., Tardif, J.-C., Tendera, M., Parkhomenko, A., Bhatt, D. L. and Steg, P. G. (2018) Relationships between components of blood pressure and cardiovascular events in patients with stable coronary artery disease and hypertension. Hypertension, 71, pp. 168-176. (doi:10.1161/HYPERTENSIONAHA.117.10204) (PMID:29084876)

Lang, I. M., Badr-Eslam, R., Greenlaw, N., Young, R. and Steg, P. G. (2017) Management and clinical outcome of stable coronary artery disease in Austria: results from 5 years of the CLARIFY registry. Wiener Klinische Wochenschrift, 129(23-24), pp. 879-892. (doi:10.1007/s00508-017-1248-1) (PMID:28913755) (PMCID:PMC5860132)

Chee, K. H., Choo, G. H., Jamaluddin, A. N., Mahendran, K., Greenlaw, N. and Krishnan, C. (2017) Clinical characteristics, treatment and 2-year outcomes in Malaysian and Bruneian patients with stable coronary artery within the worldwide CLARIFY registry. Medical Journal of Malaysia, 72(5), pp. 282-285. (PMID:29197883)

Sorbets, E., Greenlaw, N., Ferrari, R., Ford, I. , Fox, K. M., Tardif, J.-C., Tendera, M. and Steg, P. G. (2017) Rationale, design, and baseline characteristics of the CLARIFY registry of outpatients with stable coronary artery disease. Clinical Cardiology, 40(10), pp. 797-806. (doi:10.1002/clc.22730) (PMID:28561986) (PMCID:PMC5697615)

Petrie, J. R. et al. (2017) Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial. Lancet Diabetes and Endocrinology, 5(8), pp. 597-609. (doi:10.1016/S2213-8587(17)30194-8) (PMID:28615149)

Kalra, P. R. et al. (2017) Hemoglobin and change in hemoglobin status predict mortality, cardiovascular events and bleeding in stable coronary artery disease. American Journal of Medicine, 130(6), pp. 720-730. (doi:10.1016/j.amjmed.2017.01.002) (PMID:28109968)

MacDonald, T. M. et al. (2017) Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT). European Heart Journal, 38(23), pp. 1843-1850. (doi:10.1093/eurheartj/ehw387) (PMID:27705888)

Parma, Z. et al. (2017) Differences in outcomes in patients with stable coronary artery disease managed by cardiologists versus non-cardiologists: the international prospective CLARIFY registry. Polish Archives of Internal Medicine, 127(2), pp. 107-114. (doi:10.20452/pamw.3902)

Thomas, K. S., Ormerod, A. D., Craig, F., Greenlaw, N., Norrie, J., Mitchell, E., Mason, J. M., Johnston, G. A., Wahie, S. and Williams, H. C. (2016) Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: a prospective cohort study. Journal of the American Academy of Dermatology, 75(5), pp. 940-949. (doi:10.1016/j.jaad.2016.06.016) (PMID:27502313)

Vidal-Petiot, E., Ford, I. , Greenlaw, N., Ferrari, R., Fox, K. M., Tardif, J.-C., Tendera, M., Tavazzi, L., Bhatt, D. L. and Steg, P. G. (2016) Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study. Lancet, 388(10056), pp. 2142-2152. (doi:10.1016/S0140-6736(16)31326-5) (PMID:27590221)

Cooper, S.-A. et al. (2016) Towards onset prevention of cognition decline in adults with Down syndrome (The TOP-COG study): a pilot randomised controlled trial. Trials, 17, 370. (doi:10.1186/s13063-016-1370-9) (PMID:27473843) (PMCID:PMC4966871)

McMurray, J. J.V. et al. (2016) Aliskiren, enalapril, or aliskiren and enalapril in heart failure. New England Journal of Medicine, 374(16), pp. 1521-1532. (doi:10.1056/NEJMoa1514859) (PMID:27043774)

Alcocer-Gamba, M. A., Martínez-Sánchez, C., Verdejo-Paris, J., Ferrari, R., Fox, K., Greenlaw, N. and Steg Philippe, G. (2015) Heart rate and use of -blockers in Mexican stable outpatients with coronary artery disease. Archivos de Cardiología de México, pp. 270-277. (doi:10.1016/j.acmx.2015.01.004) (PMID:25921309)

Ponikowski, P. et al. (2015) The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study. European Journal of Heart Failure, 17(3), pp. 329-339. (doi:10.1002/ejhf.229) (PMID:25683972) (PMCID:PMC4413361)

Sbarouni, E., Voudris, V., Georgiadou, P., Hamilos, M., Steg, G., Fox, K. M., Greenlaw, N. and Vardas, P. E. (2015) Heart rate and b-blockade in stable coronary artery disease in Greece. Hellenic Journal of Cardiology, 56, pp. 112-117.

Erglis, A., Mintale, I., Latkovskis, G., Balode, I., Jegere, S., Bajare, I., Rozenbergs, A., Greenlaw, N., Ferrari, R. and Steg, P. G. (2015) Management of coronary artery disease patients in Latvia compared with practice in Central-Eastern Europe and globally: analysis of the CLARIFY registry. Medicina, 51(4), pp. 240-246. (doi:10.1016/j.medici.2015.05.004) (PMID:26424189)

Fauchier, L., Greenlaw, N., Ferrari, R., Ford, I. , Fox, K. M., Tardif, J.-C., Tendera, M. and Steg, P. G. (2015) Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International CLARIFY registry. PLoS ONE, 10(4), e0125164. (doi:10.1371/journal.pone.0125164) (PMID:25915904) (PMCID:PMC4411156)

Ormerod, A.D., Thomas, K.S., Craig, F.E., Mitchell, E., Greenlaw, N., Norrie, J., Mason, J.M., Walton, S., Johnston, G.A. and Williams, H.C. (2015) Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial. British Medical Journal, 2015(350), h2958. (doi:10.1136/bmj.h2958) (PMID:26071094) (PMCID:PMC4469977)

Cooper, S.-A. et al. (2014) Practice nurse health checks for adults with intellectual disabilities: a cluster-design, randomised controlled trial. Lancet Psychiatry, 1(7), pp. 511-521. (doi:10.1016/S2215-0366(14)00078-9)

Sbarouni, E., Voudris, V., Georgiadou, P., Hamilos, M., Steg, P. G., Fox, K. M., Greenlaw, N., Ferrari, R. and Vardas, P. E. (2014) Clinical presentation and management of stable coronary artery disease: insights from the international prospective CLARIFY registry - results from the Greek National Cohort. Hellenic Journal of Cardiology, 55, pp. 442-447. (PMID:25432195)

Steg, P. G. et al. (2014) Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the international observational CLARIFY registry. JAMA Internal Medicine, 174(10), pp. 1651-1659. (doi:10.1001/jamainternmed.2014.3773) (PMID:25110899)

Tendera, M. et al. (2014) Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registry. International Journal of Cardiology, 176(1), pp. 119-124. (doi:10.1016/j.ijcard.2014.06.052) (PMID:25042656)

Danchin, N., Ferrieres, J., Guenoun, M., Cattan, S., Rushton-Smith, S. K., Greenlaw, N., Ferrari, R. and Steg, P. G. (2014) Management of outpatients in France with stable coronary artery disease. Findings from the prospeCtive observational LongitudinAl RegIstry oF patients with stable coronary arterY disease (CLARIFY) registry. Archives of Cardiovascular Diseases, 107(8-9), pp. 452-461. (doi:10.1016/j.acvd.2014.06.001) (PMID:25128934)

Zamorano, J. L., García-Moll, X., Ferrari, R. and Greenlaw, N. (2014) Demographic and clinical characteristics of patients with stable coronary artery disease: results from the CLARIFY registry in Spain. Revista Española de Cardiología (English Edition), 67(7), pp. 538-544. (doi:10.1016/j.rec.2013.10.020) (PMID:24952393)

Gandhi, S., Dorian, P., Greenlaw, N., Tardif, J.-C., Steg, P.G., Huynh, T., Wong, G.C., Love, M.P., Poirier, P. and Goodman, S.G. (2014) Characteristics and evidence-based management of stable coronary artery disease patients in Canada compared with the rest of the world: insights from the CLARIFY registry. Canadian Journal of Cardiology, 30(1), pp. 132-137. (doi:10.1016/j.cjca.2013.07.680) (PMID:24238756)

Balode, I., Mintāle, I., Latkovskis, G., Jēgere, S., Narbute, I., Bajāre, I., Greenlaw, N., Steg, P. G., Ferrari, R. and Ērglis, A. (2014) Insufficient control of heart rate in stable coronary artery disease patients in Latvia. Medicina, 50(5), pp. 295-302. (doi:10.1016/j.medici.2014.10.005) (PMID:25488166)

Ferrari, R., Ford, I. , Greenlaw, N., Tardif, J.-C., Tendera, M., Abergel, H., Fox, K., Hu, D., Shalnova, S. and Steg, P. G. (2014) Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: data from the contemporary CLARIFY registry. European Journal of Preventive Cardiology, 22(8), pp. 1056-1065. (doi:10.1177/2047487314547652) (PMID:25147344)

Kalra, P. R. et al. (2014) Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patients. PLoS ONE, 9(7), e102335. (doi:10.1371/journal.pone.0102335) (PMID:25051258) (PMCID:PMC4106833)

McMurray, J. et al. (2014) A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure. European Heart Journal, 36(7), pp. 434-439. (doi:10.1093/eurheartj/ehu455) (PMID:25416329) (PMCID:PMC4328198)

Stępińska, J., Marona, M., Greenlaw, N. and Steg, G. (2014) Heart rate and the use of beta-blockers in stable outpatients with coronary artery disease: Polish baseline results of the CLARIFY registry. Kardiologia Polska, 72(11), pp. 1156-1164. (doi:10.5603/KP.a2014.0134) (PMID:25001472)

Cameron, E.J. et al. (2013) Randomised controlled trial of azithromycin in smokers with asthma. European Respiratory Journal, 42(5), pp. 1412-1415. (doi:10.1183/09031936.00093913)

Ferrari, R., Abergel, H., Ford, I. , Fox, K.M., Greenlaw, N., Steg, P.G., Hu, D., Tendera, M. and Tardif, J. (2013) Gender- and age-related differences in clinical presentation and management of outpatients with stable coronary artery disease. International Journal of Cardiology, 167(6), pp. 2938-2943. (doi:10.1016/j.ijcard.2012.08.013) (PMID:22985742)

Wright, F., Boyle, S., Baxter, K., Gilchrist, L., Nellaney, J., Greenlaw, N. and Forde, L. (2013) Understanding the relationship between weight loss, emotional well-being and health-related quality of life in patients attending a specialist obesity weight management service. Journal of Health Psychology, 18(4), pp. 574-586. (doi:10.1177/1359105312451865)

Filippatos, G. et al. (2013) Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial. European Journal of Heart Failure, 15(11), pp. 1267-1276. (doi:10.1093/eurjhf/hft099)

Jackson, C.E. et al. (2013) Spectral microvolt T-wave alternans testing has no prognostic value in patients recently hospitalized with decompensated heart failure. European Journal of Heart Failure, 15(11), pp. 1253-1261. (doi:10.1093/eurjhf/hft085)

Jackson, C.E. et al. (2013) Feasibility/eligibility of T-wave alternans testing in patients with heart failure: should we rethink our current modus operandi?: reply. European Journal of Heart Failure, 14(6), pp. 676-677. (doi:10.1093/eurjhf/hfs050)

Smith, S., Allan, A., Greenlaw, N., Finlay, S. and Isles, C. (2013) Emergency medical admissions, deaths at weekends and the public holiday effect. Cohort study. Emergency Medicine Journal, 2014(31), pp. 30-34. (doi:10.1136/emermed-2012-201881)

Van Craenenbroeck, E.M., Conraads, V.M., Greenlaw, N., Gaudesius, G., Mori, C., Ponikowski, P. and Anker, S.D. (2013) The effect of intravenous ferric carboxymaltose on red cell distribution width: a subanalysis of the FAIR-HF study. European Journal of Heart Failure, 15(7), pp. 756-762. (doi:10.1093/eurjhf/hft068)

Steg, P.G., Greenlaw, N., Tardif, J.-C., Tendera, M., Ford, I. , Kaab, S., Abergel, H., Fox, K.M. and Ferrari, R. (2012) Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry. European Heart Journal, 33(22), pp. 2831-2840. (doi:10.1093/eurheartj/ehs289)

Lowrie, R., Mair, F.S. , Greenlaw, N., Forsyth, P., Jhund, P.S. , McConnachie, A. , Rae, B. and McMurray, J.J.V. (2012) Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction. European Heart Journal, 33(3), pp. 314-324. (doi:10.1093/eurheartj/ehr433)

Jackson, C.E. et al. (2012) Microvolt T-wave alternans (MTWA) testing in 'real world' heart failure (HF): a study of prevalence and incremental prognostic value. Heart, 2012(98), A12. (doi:10.1136/heartjnl-2012-301877b.17)

Jackson, C.E. et al. (2012) Microvolt T-wave alternans testing should be used to guide arrhythmic therapy in heart failure patients: reply. European Journal of Heart Failure, 14(6), p. 678. (doi:10.1093/eurjhf/hfs077)

Jackson, C.E. et al. (2012) Profile of microvolt T-wave alternans testing in 1003 patients hospitalized with heart failure. European Journal of Heart Failure, 14(4), pp. 377-386. (doi:10.1093/eurjhf/hfs010)

Morrison, D.S., Boyle, S., Morrison, C., Allardice, G., Greenlaw, N. and Forde, L. (2012) Evaluation of the first phase of a specialist weight management programme in the UK National Health Service: prospective cohort study. Public Health Nutrition, 15(1), pp. 28-38. (doi:10.1017/S1368980011001625)

Steg, P.G., Ferrari, R., Ford, I. , Greenlaw, N., Tardif, J.-C., Tendera, M., Abergel, H. and Fox, K. (2012) Heart rate and use of beta-blockers in stable outpatients with coronary artery disease. PLoS ONE, 7(5), e36284. (doi:10.1371/journal.pone.0036284) (PMID:22570699) (PMCID:PMC3343045)

Lowrie, R. et al. (2011) The Heart failure and Optimal Outcomes from Pharmacy Study (HOOPS): rationale, design, and baseline characteristics. European Journal of Heart Failure, 13(8), pp. 917-924. (doi:10.1093/eurjhf/hfr083)

McArdle, C.S., McMillan, D.C. , Greenlaw, N. and Morrison, D.S. (2010) Adjuvant radiotherapy and chemotherapy in breast cancer: 30 year follow-up of survival. BMC Cancer, 10(1), p. 398. (doi:10.1186/1471-2407-10-398)

Robertson, G., Greenlaw, N., Bray, C. and Morrison, D. (2010) Explaining the effects of socio-economic deprivation on survival in a national prospective cohort study of 1909 patients with head and neck cancers. Cancer Epidemiology, 34(6), pp. 682-688.

Conference or Workshop Item

Hughes-Mccormack, L. et al. (2016) Quality of primary health care of 5,000 people with intellectual disabilities in Scotland. 2016 IASSIDD World Congress, Melbourne, Australia, 14-19 Aug 2016. p. 685. (doi:10.1111/jir.12305)

This list was generated on Tue Jul 16 07:35:20 2019 BST.